Charles Jillings, CEO of Utilico, energized by strong economic momentum across Latin America. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksInter. Pers. Regulatory News (IPF)

Share Price Information for Inter. Pers. (IPF)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 106.00
Bid: 105.00
Ask: 106.00
Change: 0.50 (0.47%)
Spread: 1.00 (0.952%)
Open: 106.00
High: 106.50
Low: 105.00
Prev. Close: 105.50
IPF Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Delay of year-end results announcement

26 Feb 2024 07:00

RNS Number : 3530E
International Personal Finance Plc
26 February 2024
 

26 February 2024

 

International Personal Finance plc

Delay of year-end results announcement

 

International Personal Finance plc (the "Group"), the provider of unsecured consumer credit to underserved consumers in nine countries, is delaying the announcement of its year-end results for the fiscal year ending 31 December 2023 due to the receipt by Provident Polska, the Group's Polish business, of a regulatory communication from Komisja Nadzoru Finansowego (KNF), the Polish Financial Supervision Authority. The letter details the KNF's views on how existing laws and regulations relating to non-interest fees should be interpreted by credit card issuers. The Group is considering the potential impact of the communication from the KNF on the performance of Provident Polska and whether this needs to be considered in finalising the Group's 2023 year-end results.

 

The Group understands that the letter was provided to all regulated lenders operating in the Polish credit card market. The Group is therefore reviewing, with the assistance of external counsel, what the impact of this sector-wide communication might be and whether it constitutes a significant change to the existing approach taken by the KNF. 

 

The Group confirms that its year-end results reflect a stronger than expected trading performance in 2023 and this momentum has continued in early 2024. The 2023 results will be deferred until the contents of the KNF letter can be considered fully by management and the audit process completed. As the letter was only received in the last few days, the Group considers it prudent to take the time to understand the contents of the communication fully, and this work is expected to take around a week to complete, following which the results will be released.

 

The Group's Polish business has an excellent track record of adapting to the evolving regulatory environment and has developed a broad range of products as it continues to play an important role in providing credit for underbanked and underserved consumers in the Polish market. Polish credit card receivables represent just over 5% of the Group's receivables and approximately 25% of overall receivables in Poland.

 

 

Investor relations contact: For any inquiries related to this announcement, please contact Rachel Moran on +44 (0)7760 167637.

 

This announcement contains forward-looking statements that involve risks and uncertainties. Actual results may differ materially from those expressed or implied by such statements.

This announcement contains inside information which is disclosed in accordance with the Market Abuse Regime.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCBCGDDRSDDGSU
Date   Source Headline
8th Apr 20241:13 pmRNSDirector/PDMR Shareholding
5th Apr 202410:00 amRNSDirector/PDMR Shareholding
4th Apr 202410:48 amRNSDirector/PDMR Shareholding
3rd Apr 20243:29 pmRNSDirector/PDMR Shareholding
2nd Apr 20247:00 amRNSTotal Voting Rights
27th Mar 20245:09 pmRNSDirector/PDMR Shareholding
25th Mar 20244:44 pmRNSAnnual Financial Report and Notice of AGM
21st Mar 20245:09 pmRNSDirector/PDMR Shareholding
19th Mar 20243:56 pmRNSDirector/PDMR Shareholding
18th Mar 20244:11 pmRNSDirector/PDMR Shareholding
15th Mar 202410:38 amRNSFinal Dividend Timetable Correction
14th Mar 20247:00 amRNSFinal Results and Accounts
26th Feb 20247:00 amRNSDelay of year-end results announcement
8th Feb 20247:00 amRNSDirector/PDMR Shareholding
27th Dec 20239:08 amRNSHolding(s) in Company
14th Dec 202311:24 amRNSPublication of Final Terms
24th Nov 20237:02 amRNSDirector/PDMR Shareholding
24th Nov 20237:00 amRNSFinal Confirmation & Results of Exchange Offer
17th Nov 20233:18 pmRNSHolding(s) in Company
16th Nov 20237:00 amRNSAppointment of Joint Broker
14th Nov 20233:09 pmRNSHolding(s) in Company
8th Nov 20237:00 amRNSNotice of Investor Webinar - 7 December 2023
3rd Nov 20234:14 pmRNSIssuance and amendment to Final Terms
2nd Nov 20231:29 pmRNSCash Offer Launch
2nd Nov 20231:18 pmRNSExchange Offer
2nd Nov 20231:16 pmRNSPublication of a Prospectus
26th Oct 20237:01 amRNSRoadshow Announcement
26th Oct 20237:00 amRNSQ3 2023 Trading Update
25th Oct 20232:12 pmRNSChange of Senior Independent Director
24th Oct 20233:19 pmRNSPublication of Final Terms - Replacement Notice
24th Oct 20237:00 amRNSPublication of Final Terms
20th Oct 20237:00 amRNSUpdate on Annual General Meeting 2023 Vote
2nd Oct 20237:00 amRNSTotal Voting Rights
14th Sep 20231:46 pmRNSDirector/PDMR Shareholding
1st Sep 20237:00 amRNSTotal Voting Rights
24th Aug 20234:35 pmRNSPublication of a Prospectus
1st Aug 20237:00 amRNSHalf-year Report
13th Jul 202311:14 amRNSHolding(s) in Company
3rd Jul 20232:30 pmRNSTotal Voting Rights
3rd Jul 20239:20 amRNSBlock listing Interim Review
1st Jun 20237:00 amRNSTotal Voting Rights
11th May 20234:48 pmRNSDirector/PDMR Shareholding
4th May 202311:17 amRNSDirector/PDMR Shareholding
2nd May 202312:28 pmRNSTotal Voting Rights
27th Apr 20234:27 pmRNSResult of AGM
27th Apr 20237:00 amRNSQ1 2023 Trading Update
19th Apr 20234:44 pmRNSNotice of Investor Briefing - 10 May 2023
6th Apr 20232:54 pmRNSDirector/PDMR Shareholding
4th Apr 20234:42 pmRNSDirector/PDMR Shareholding
3rd Apr 20233:37 pmRNSTotal Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.